Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
192
394
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DGNS stock under the Base Case scenario is 254.41 IDR. Compared to the current market price of 230 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Diagnos Laboratorium Utama PT Tbk
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DGNS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Diagnos Laboratorium Utama PT Tbk
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Diagnos Laboratorium Utama PT Tbk
Balance Sheet Decomposition
Diagnos Laboratorium Utama PT Tbk
Current Assets | 95.6B |
Cash & Short-Term Investments | 9.7B |
Receivables | 50.6B |
Other Current Assets | 35.3B |
Non-Current Assets | 194.8B |
Long-Term Investments | 13B |
PP&E | 174.4B |
Intangibles | 1.3B |
Other Non-Current Assets | 6.1B |
Current Liabilities | 28.3B |
Accounts Payable | 11.6B |
Accrued Liabilities | 2.7B |
Other Current Liabilities | 14B |
Non-Current Liabilities | 65.6B |
Long-Term Debt | 62.9B |
Other Non-Current Liabilities | 2.7B |
Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk
Revenue
|
155.5B
IDR
|
Cost of Revenue
|
-88.2B
IDR
|
Gross Profit
|
67.3B
IDR
|
Operating Expenses
|
-73B
IDR
|
Operating Income
|
-5.7B
IDR
|
Other Expenses
|
965.1m
IDR
|
Net Income
|
-4.8B
IDR
|
Free Cash Flow Analysis
Diagnos Laboratorium Utama PT Tbk
IDR | |
Free Cash Flow | IDR |
DGNS Profitability Score
Profitability Due Diligence
Diagnos Laboratorium Utama PT Tbk's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Diagnos Laboratorium Utama PT Tbk's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
DGNS Solvency Score
Solvency Due Diligence
Diagnos Laboratorium Utama PT Tbk's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Diagnos Laboratorium Utama PT Tbk's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DGNS Price Targets Summary
Diagnos Laboratorium Utama PT Tbk
Dividends
Current shareholder yield for DGNS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. The company employs 54 full-time employees The company went IPO on 2021-01-15. The firm is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouses, eye banks, sperm banks and blood banks, organ transplant banks, and other medical support services. The company operates through providing health services using laboratories segment. The Company’s products and services include clinical pathology laboratory, anatomy pathology laboratory, genomic laboratory, homecare health services, corporate health services, and Covid-19 checkup. The firm serves markets, such as Jakarta, Depok, Bali, Bandung, Bekasi, Padang, Makassar, Tangerang Selatan, Dumai, Batam, Purwakarta, Karawang, and Brebes. The company has branch offices in Ciputat (South Tangerang), Denpasar (Bali), Padang (West Sumatra), and Makassar, South Sulawesi.
Contact
IPO
Employees
Officers
The intrinsic value of one DGNS stock under the Base Case scenario is 254.41 IDR.
Compared to the current market price of 230 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 10%.